Clear Labs Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
75
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$60M
- Investors
-
29
Clear Labs General Information
Description
Developer of end-to-end, integrated genomics system designed to simplify complex diagnostics for clinical and applied markets. The company's platform provides a fully automated platform that brings together acid sequencing, robotics, and cloud-based bioinformatics and analytics, it is liberating genomics to all by providing our customers with everything they need to perform sequencing, enabling labs, hospitals, and companies with genomic insights.
Contact Information
Website
www.clearlabs.comCorporate Office
- 1559 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 1559 Industrial Road
- San Carlos, CA 94070
- United States
Clear Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C) | 26-May-2021 | $60M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series B1) | 28-Aug-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B1) | 30-Oct-2018 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 30-Aug-2017 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Mar-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 05-Oct-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Feb-2014 | $1.7M | $1.7M | Completed | Generating Revenue | |
| 1. Angel (individual) | Completed | Startup |
Clear Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A2 | 6,333,936 | $0.000100 | 8% | $1.09 | $1.09 | 1x | $1.09 | 6.76% |
| Series A | 4,928,517 | $0.000100 | 8% | $0.35 | $0.35 | 1x | $0.35 | 5.26% |
Clear Labs Comparisons
Industry
Financing
Details
Clear Labs Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Pacific Biosciences | Formerly VC-backed | Menlo Park, CA | ||||
| Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
| Flagship Biosciences | Venture Capital-Backed | Broomfield, CO |
Clear Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Clear Labs Patents
Clear Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230417787-A1 | Fully automated sample processing platform from extraction to sequencing | Pending | 24-Jun-2022 | ||
| US-20230417786-A1 | Fully automated sample processing platform from extraction to sequencing | Pending | 24-Jun-2022 | ||
| US-11248265-B1 | Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens | Active | 19-Nov-2020 | ||
| US-20220154270-A1 | Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens | Pending | 19-Nov-2020 | ||
| GB-2605477-A | Systems and processes for distinguishing sequences from microorganisms | Inactive | 19-Nov-2020 | C12Q1/689 |
Clear Labs Executive Team (14)
| Name | Title | Board Seat |
|---|---|---|
| Sasan Amini Ph.D | Co-Founder, Chief Executive Officer & Board Member | |
| Edward Fan | Chief Financial Officer | |
| Ramin Khaksar Ph.D | Chief Scientific Officer, Chief Operating Officer & Founding Member | |
| Henrik Gehrmann | Senior Vice President of Engineering |
Clear Labs Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gaurav Garg | Wing Venture Capital | Board Member | |
| Greg Yap | Menlo Ventures | Board Member | |
| Michael Robach | Self | Board Member | |
| Mostafa Ronaghi Ph.D | Phi-X Capital | Board Member | |
| Sasan Amini Ph.D | Clear Labs | Co-Founder, Chief Executive Officer & Board Member |
Clear Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Clear Labs Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dafgårds | Corporation | Minority | ||
| HBM Genomics | Venture Capital | Minority | ||
| Morgan Stanley | Investment Bank | Minority | ||
| Nimble Partners | Venture Capital | Minority | ||
| Prime Partners | Venture Capital | Minority |
Clear Labs FAQs
-
When was Clear Labs founded?
Clear Labs was founded in 2014.
-
Who is the founder of Clear Labs?
Sasan Amini Ph.D and Mahni Ghorashi Ph.D are the founders of Clear Labs.
-
Who is the CEO of Clear Labs?
Sasan Amini Ph.D is the CEO of Clear Labs.
-
Where is Clear Labs headquartered?
Clear Labs is headquartered in San Carlos, CA.
-
What is the size of Clear Labs?
Clear Labs has 75 total employees.
-
What industry is Clear Labs in?
Clear Labs’s primary industry is Other Healthcare Technology Systems.
-
Is Clear Labs a private or public company?
Clear Labs is a Private company.
-
What is the current valuation of Clear Labs?
The current valuation of Clear Labs is .
-
What is Clear Labs’s current revenue?
The current revenue for Clear Labs is .
-
How much funding has Clear Labs raised over time?
Clear Labs has raised $147M.
-
Who are Clear Labs’s investors?
Dafgårds, HBM Genomics, Morgan Stanley, Nimble Partners, and Prime Partners are 5 of 29 investors who have invested in Clear Labs.
-
Who are Clear Labs’s competitors?
Oxford Nanopore Technologies, Illumina, Pacific Biosciences, Standard BioTools, and Flagship Biosciences are some of the 11 competitors of Clear Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
